Effectiveness of an adapted inpatient treatment with Schema Therapy and milieu therapy for SUD and comorbid PD in a religious setting (A baseline controlled case series design)

o sponsors0 个研究点目标入组 12 人开始时间: 待定最近更新: 2024年2月28日

试验速览

暂无简介。

•Inclusion criteria are that patients have an indication for treatment in an inpatient setting for SUD (substance use disorder) at the 4life clinic at the Hoop ggz, following the Dutch guidelines (De Beer & Van de Glind, 2009). Patients have a diagnosis of DSM-5 SUD and have minimally five PD traits (this is seen as clinically significant for PD (Verheul, Bartak, & Widiger, 2007)), age 18-65 years, with an indication of at least a normal intelligence based on a completed primary and secondary education and clinical impression, and a willingness to participate in the study confirmed by a signed informed consent.

•Exclusion criteria are an severe autism spectrum disorder, schizophrenia or other psychotic disorders, and the presence of significant risk for suicide based on psychiatric evaluation. Other exclusion criteria are the current use of heroin, methadone or another heroin replacement, acute delirium symptoms, or have otherwise specific medical needs. These clients are refered to a more medical oriented inpatient detoxification.
•Further, we exclude patients whose waiting list times are less than two weeks, because that allows insufficient time to gather three necessary baseline observations.

发起方

o sponsors